DI RAIMONDO, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 9.835
EU - Europa 3.625
AS - Asia 1.486
AF - Africa 40
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 15.012
Nazione #
US - Stati Uniti d'America 9.821
IT - Italia 1.294
CN - Cina 812
UA - Ucraina 563
FI - Finlandia 540
SG - Singapore 478
DE - Germania 307
IE - Irlanda 233
GB - Regno Unito 206
RU - Federazione Russa 97
RO - Romania 83
SE - Svezia 82
FR - Francia 81
IN - India 51
BE - Belgio 49
HK - Hong Kong 41
CI - Costa d'Avorio 32
TR - Turchia 25
NL - Olanda 22
IR - Iran 17
KR - Corea 14
JP - Giappone 13
CH - Svizzera 12
CA - Canada 11
CZ - Repubblica Ceca 11
PL - Polonia 10
BR - Brasile 8
EU - Europa 8
MK - Macedonia 7
AT - Austria 6
GR - Grecia 6
LB - Libano 6
PK - Pakistan 5
BD - Bangladesh 4
CL - Cile 4
IQ - Iraq 4
AU - Australia 3
ES - Italia 3
HU - Ungheria 3
MX - Messico 3
TN - Tunisia 3
BG - Bulgaria 2
CY - Cipro 2
EG - Egitto 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
VN - Vietnam 2
ZA - Sudafrica 2
AL - Albania 1
DK - Danimarca 1
DZ - Algeria 1
ID - Indonesia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SM - San Marino 1
Totale 15.012
Città #
Fairfield 1.525
Chandler 866
Ashburn 863
Woodbridge 815
Houston 676
Seattle 607
Wilmington 562
Cambridge 524
Ann Arbor 452
Singapore 391
Jacksonville 303
Dublin 233
Medford 226
Palermo 223
Des Moines 214
Nanjing 162
Princeton 144
Altamura 130
New York 113
San Diego 102
Lawrence 99
Tulsa 79
Beijing 77
Boardman 72
Dearborn 70
Jinan 61
Ludwigshafen am Rhein 56
Milan 54
Nanchang 52
Santa Clara 50
Brussels 49
Hebei 47
Rome 46
London 39
Tianjin 37
Changsha 33
Shenyang 33
Abidjan 32
Central 32
Jiaxing 32
Falls Church 28
Los Angeles 28
Zhengzhou 28
Ningbo 26
Düsseldorf 25
Munich 25
Bremen 23
Guangzhou 22
Kumar 22
Venice 21
Izmir 20
Phoenix 19
San Paolo di Civitate 19
Auburn Hills 18
Verona 18
Hangzhou 17
Helsinki 17
Saint Petersburg 17
Redwood City 16
Norwalk 15
Pune 15
Columbus 14
Lanzhou 14
Kilburn 13
Orange 12
Seongnam 12
Taizhou 12
Tehran 12
Agrigento 11
Kunming 11
San Mateo 9
Tokyo 9
Foggia 8
Haikou 8
Naples 8
Shanghai 8
Taiyuan 8
Forest City 7
Frankfurt am Main 7
Fuzhou 7
Genova 7
Moscow 7
Napoli 7
Paris 7
Amsterdam 6
Castelbuono 6
Catania 6
Chicago 6
Dallas 6
Hong Kong 6
Prilep 6
Tappahannock 6
Toronto 6
Bagheria 5
Bari 5
Castelfiorentino 5
Hanover 5
Kraków 5
Mirano 5
Torino 5
Totale 10.927
Nome #
Prevenzione del reictus 329
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke 232
Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. 211
HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis 206
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 200
Prevalence of arterial hypertension and characteristics of nocturnal blood pressure profile of asthma patients according to therapy and severity of the disease: The bada study 186
Fetuin-A and CD40L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables 182
Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype 178
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 173
QT Indexes in Cirrhotic Patients: Relationship with Clinical Variables and Potential Diagnostic Predictive Value. 168
Aceruloplasminemia: a case report 162
Cerebrovascular risk factors and clinical classification of strokes 157
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. 157
Diabetic and non-diabetic subjects with ischemic stroke: Differences, subtype distribution and outcome 155
Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke 155
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 152
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 150
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage. 150
ADIPONECTIN, RESISTIN AND IL-6 PLASMA LEVELS IN SUBJECTS WITH DIABETIC FOOT AND POSSIBLE CORRELATION WITH CLINICAL VARIABLES AND CARDIOVASCULAR CO-MORBIDITY 149
Mediterranean Diet in patients with acute ischemic stroke: Relationships between Mediterranean Diet score, diagnostic subtype, and stroke severity index 148
Predictors of outcome in acute ischemic cerebrovascular syndromes: The GIFA study 146
Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). 146
Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. 144
Metabolic and anti-inflammatory effects of a home-based programme of aerobic physical exercise 143
Editorial: Management of Elevated Heart Rate in Essential Hypertension: Pathophysiological Insights and Therapeutic Approach. 142
Effects of physical exercise on inflammatory markers of atherosclerosis. 141
Peripheral Frequency of CD4+ CD28- Cells in Acute Ischemic Stroke: Relationship With Stroke Subtype and Severity Markers. 139
Immuno-inflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. 138
Arterial stiffness indexes in acute ischemic stroke: relationship with stroke subtype. 138
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 137
Mediterranean Diet Adherence and Congestive Heart Failure: Relationship With Clinical Severity and Ischemic Pathogenesis 137
4. Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine. 136
Immune-inflammatory and metabolic effects of high dose furosemide plus hypertonic saline solution (HSS) treatment in cirrhotic subjects with refractory ascites 136
Use of QT intervals for a more accurate diagnose of syncope and evaluation of syncope severity. 135
Twenty-four hour ambulatory blood pressure monitoring to evaluate effects on blood pressure of physical activity in hypertensive patients. 131
Antiplatelets in stroke prevention 131
INFLAMMATORY CYTOKINES IN ACUTE ISCHEMIC STROKE. 130
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 129
Antiplatelet treatment in ischemic stroke treatment. 128
Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot 127
Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. 127
Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study. 127
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome. 125
Are the Myokines the Mediators of Physical Activity-Induced Health Benefits? 125
An atypical clinical presentation of acute appendicitis in a young man with midgut malrotation 123
Ambulatory Arterial Stiffness Index (AASI) is Unable to Estimate Arterial Stiffness of Hypertensive Subjects: Role of Nocturnal Dipping of Blood Pressure. 123
Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study) 123
Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population 122
New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention. 122
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. 120
The "Neurocentric" Approach to Essential Hypertension: How Reliable is the Paradigm of Hyperkinetic Hypertension? A Focus on the Sympathetic Nervous System Dysregulation in Essential Hypertensive Patients with Elevated Resting Heart Rate. 118
Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study: response to Janghorbani et al 117
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine. 116
Does sympathetic overactivation feature all hypertensives? Differences of sympathovagal balance according to night/day blood pressure ratio in patients with essential hypertension 116
Atherosclerosis as an inflammatory disease. , 115
Antivitamin K drugs in stroke prevention. 115
Management of Blood Pressure and Heart Rate in Patients with Acute Stroke. 115
Hyperhomocysteinemia in patients with cognitive impairment 112
Endothelial function and arterial stiffness indexes in subjects with acute ischemic stroke: Relationship with TOAST subtype. 112
A case control study between diabetic and non-diabetic subjects with ischemic stroke. 111
Non lipid, dose-dependent effects of pravastatin treatment on hemostatic system and inflammatory response 110
Authors’ reply 110
Insufficienza renale acuta da necrosi tubulare acuta iatrogena 108
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke 108
Endothelial function, adipokine serum levels and white matter hyperintesities in subjects with diabetic foot syndrome. 108
Immunoinflammatory predictors of stroke in patients with chronic non valvular atrial fibrillation (NVAF). 106
Successful “salvage” therapy of intravenous cyclophosphamide for Refractory Polymyositis in a elderly patient: a case report 105
Stroke subtypes and their possible implication in stroke prevention drug strategies 105
New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients. 105
Inflammation in ischemic stroke subtypes. 104
Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site 103
Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. 103
Plasma derived protein C in severe sepsis: report of two cases 102
Heart rate variability in sick sinus syndrome: does it have a diagnostic role? 101
Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes with and without diabetic foot. ; 99
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial 99
Sodium thiosulfate not always resolves calciphylaxis: an ambiguous response 96
A re-entry tachycardia triggered by the spontaneous interruption of an atrial tachycardia. 96
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn's disease: The brain^gut^ vascular axis 95
Ischemic stroke in patients with diabetic foot 93
Predictors of outcome in acute ischemic cerebrovascular syndromes: The GIFA Study 93
Episodes of second-degree ventriculo-atrial block during ventricular tachycardia. 93
Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: Association with time of onset and diabetic state 92
Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders 92
Una presentazione clinica atipica di appendicite acuta in un giovane con malposizione intestinale 89
Changes in natriuretic peptides and cytokines plasma levels in patients with heart failure, after high dose of furosemide plus small volume saline solution (HSS) and after an acute saline loading 89
Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study. 88
Early high-dosage atorvastatin treatment improved serum immune-inflammatory markers and functional outcome in acute ischemic strokes classified as large artery atherosclerotic stroke: A randomized trial 88
Immunoinflammatory activation of the acute phase of ischemic stroke in relation to time of symptoms onset, diabetic state and diagnostic subtype. 85
Attivazione immunoinfiammatoria della fase acuta e diatesi trombofilica in soggetti con ictus ischemico acuto. Studio prospettico di confronto tra diabetici e non diabetici. ; 83
Descrizione del quarto caso di aceruloplasminemia familiare diagnosticato in Italia. 83
Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascites. 82
Relationship between adherence to the Mediterranean Diet, intracerebral hemorrhage, and its location. 82
Insights from experiences on antiplatelet drugs in stroke prevention: A review 82
Acquired haemophilia A: a case repor 81
PREVENTIVE AND THERAPEUTIC ROLE OF MUSCLE CONTRACTION AGAINST CHRONIC DISEASES 81
Risk Factors profile and clinical outcome of ischemic stroke patients admitted in a department of Internal Medicine and classified by TOAST classification 80
Nd:YAG laser induced E' centers probed by in situ absorption measurements 79
Successful salvage therapy of intravenous cyclophosphamide for refractory polymyositis in an elderly patient: a case report. 79
Dexcription of the fourth case of Aceruloplasminemia found in Italy. 76
Totale 12.471
Categoria #
all - tutte 64.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.112 0 0 0 0 0 432 379 247 381 150 377 146
2020/20212.158 137 170 141 185 296 111 159 122 260 199 217 161
2021/20221.801 98 370 42 42 120 72 90 108 212 186 141 320
2022/20232.521 271 451 60 258 284 359 167 199 289 20 106 57
2023/20241.178 51 173 55 113 79 282 127 65 6 47 8 172
2024/2025830 52 110 145 251 116 156 0 0 0 0 0 0
Totale 15.611